Menu

Featured News

Some of the leading stories and synthetic biology information from SynbiCITE

Save the date for our first Synthetic Biology Industrial Translation Showcase

The inaugural SynbiCITE – Synthetic Biology Industrial Translation Showcase will take place on Tuesday 5th June from 9.00am-5.00pm at the Royal Academy of Engineering

Read article

Transformational European Commission Grant dramatically accelerates novel biomaterial company Customem

CustoMem, founded in 2015 by two Imperial College London graduates, Henrik Hagemann and Gabi Santosa, has received a substantial €1.4m grant that will...

Read article

UK Synthetic Biology start-up survey 2017

The UK’s first survey of the Synthetic Biology industry following a year of significant progress.

SynbiCITE’s UK Synthetic Biology start-up survey 2017 will assess the current and potential size of the Synthetic Biology industry, looking closely at growth trends, company scale, the value of the sector, key stakeholders and the commercial impact it could have. The challenges facing the industry, such as funding and IP protection, regulatory issues and ethics will also be evaluated. The completed report will be available this summer.

SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK to accelerate the commercialisation of world-class science and emerging technologies encompassed by synthetic biology into new products, tools, processes and services.

Register for your complimentary electronic copy

Innovation, education & collaboration

Watch SynbiCITE's new film to get an insight into the potential that synthetic biology offers us all.

Synthetic biology is unlocking significant new opportunities for industries ranging from life sciences and specialty chemicals to bioenergy and waste remediation. By facilitating the creation of new tools and techniques, synbio has the potential to reshape many technologies to affect our lives positively and to reduce the impact that we have on our planet. Synbio is the engineering of biology and it’s already helping to make many businesses more effective, more productive and more environmentally friendly.

SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK which accelerates the commercialisation of world-class science and the emerging technologies encompassed by synthetic biology and engineering biology into new products, tools, processes and services.

Discover more

Resources

SynbiCITE has a number of resources available to all our partners to use for the translation of their research into new products, tools and processes.

View our resources

We partner with some of the world’s most forward-thinking organisations

We support our partners through events and training programmes including problems-solutions brokerage meetings. We provide funding of development projects including seed funding of Proof of Concept projects and follow-on funding of longer, larger projects for the development of prototypes and taking these on to pilot production scale manufacturing.

View our network

Synthetic Biology community

Take a look at the active and interactive synthetic biology community. Join the conversation and get involved.
Prokarium secures $10 million investment

Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccinesKeele...

Read article
London DNA Foundry

@DNAFoundry

  • 8
  • 6
London DNA Foundry

@DNAFoundry

  • 1
  • 2
SynbiCITE

@SynbiCITE

  • 7
  • 5
SynbiCITE

@SynbiCITE

  • 2
  • 2
Save the date for our first Synthetic Biology Industrial Translation Showcase

The inaugural SynbiCITE – Synthetic Biology Industrial Translation Showcase will take place on Tuesday 5th June from 9.00am-5.00pm at the Royal Academy of Engineering

Read article
SynbiCITE

@SynbiCITE

  • 4
  • 1
SynbiCITE

@SynbiCITE

  • 0
  • 0
SynbiCITE

@SynbiCITE

  • 0
  • 1
Transformational European Commission Grant dramatically accelerates novel biomaterial company Customem

CustoMem, founded in 2015 by two Imperial College London graduates, Henrik Hagemann and Gabi Santosa, has received a substantial €1.4m grant that will...

Read article
SynbiCITE welcomes RebelBio to London

We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itse...

Read article